AstraZeneca picks Publicis and WPP as advertising partners

October 27, 2003

AstraZeneca will work exclusively with Publicis and WPP agencies in the US following a rationalisation of its advertising partnerships.The review, …

Pension fund urges GSK to act on AIDS

October 27, 2003

The world's largest pension fund has urged GlaxoSmithKline to step up its efforts to help combat the AIDS pandemic in …

Long-awaited diabetes NSF launched

October 27, 2003

The long awaited diabetes national service framework has been launched with demanding new targets for the improvement of NHS services.By …

Investment banker to be Elan chief executive

October 27, 2003
Elan

Kelly Martin, a former senior executive at Merrill Lynch, has been named chief executive of troubled Irish pharmaceutical company Elan.The …

Industry’s legal challenge to ‘arbitrary’ pricing

October 27, 2003

European industry body EFPIA is seeking legal action against the Italian Government new reimbursement and pricing policy, which it believes …

Deadlock over access to medicines

October 27, 2003

A row over patents on diabetes and asthma drugs has produced a deadlock in talks to improve access to medicines …

Pharmacia chief tipped for Schering role

October 27, 2003

Current Pharmacia Chief Executive Fred Hassan has been tipped to take over the top job at Schering-Plough once the Pfizer/Pharmacia …

NHS diabetes czar appointed

October 27, 2003

Leading diabetes specialist Dr Sue Roberts has been appointed as the new National Clinical Director for Diabetes, and will oversee …

Roche records $2.8bn loss in 2002

October 27, 2003

Roche has recorded a $2.8 billion net loss for 2002 after writing off CHF9 billion costs following its embarrassing exit …

EU regulator submits expansion plans

October 27, 2003

Medicines regulator the EMEA has asked the European Union for a subsidy increase of nearly 13% to pay for its …

Bayer denies Lipobay cover-up

October 27, 2003

Bayer has refuted allegations that it concealed serious side-effects of its statin Lipobay before it was withdrawn in July 2001.US …

Pfizer picks US research ‘hotspot’ for trials centre

October 27, 2003

Pfizer is to build a new $35 million clinical research centre in an R&D 'hotspot' in New Haven, Connecticut.Due to …

Abbott surprised by early Humira approval

October 27, 2003

Abbott Laboratories says US approval of its rheumatoid arthritis product Humira has come earlier than expected, and will now increase …

ClinPhone signals European expansion

October 27, 2003

UK clinical trials technology company ClinPhone is to develop its European business to serve clusters of pharmaceutical and biotech companies …

The Gateway to Local Adoption Series

Latest content